Vacuolisation of human microvascular endothelial cells by enterohaemorrhagic Escherichia coli

Thrombosis and Haemostasis

Volumn 102, Issue 6, 2009, Pages 1080-1092

  Bielaszewska, Martina ^a   Bauwens, Andreas ^a   Greune, Lilo ^a   Kemper, Björn ^a   Dobrindt, Ulrich ^b   Geelen, Joyce M ^c   Kim, Kwang S ^d   Schmidt, M Alexander ^a   Karch, Helge ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

EHEC Vac; Enterohaemorrhagic E. coli; Haemolytic uraemic syndrome; Microvascular endothelial injury; Vacuolating cytotoxin

Indexed keywords

BAFILOMYCIN A1; GENOMIC DNA; NEUTRAL RED; VACUOLATING TOXIN;

ARTICLE; BACTERIAL STRAIN; BRAIN BLOOD VESSEL; CELL DEATH; CELL SURVIVAL; CELL VACUOLE; CONTROLLED STUDY; CYTOKINE RELEASE; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; ENTEROHEMORRHAGIC ESCHERICHIA COLI; GENE IDENTIFICATION; GLOMERULUS; HELICOBACTER PYLORI; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; KIDNEY BLOOD VESSEL; LYSOSOME; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; STAINING;

BACTERIAL TOXINS; BASE SEQUENCE; CELL LINE; CELLS, CULTURED; CYTOKINES; DNA PRIMERS; ENDOTHELIAL CELLS; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; MACROLIDES; MICROCIRCULATION; VACUOLES; VIRULENCE; VIRULENCE FACTORS;

EID: 72949099690     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-07-0499     Document Type: Article

References (51)

1. Karch H, Tarr PI, Bielaszewska M. Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol 2005; 295: 405-418.
2. Tarr PI, Gordon CA, Chandler WL. Shiga-toxinproducing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005; 365: 1073-1086.
3. Andreoli SP, Trachtman H, Acheson DWK, et al.. Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy. Pediatr Nephrol 2002; 17: 293-298.
4. Richardson SE, Karmali MA, Becker LE, et al.. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol 1988; 19: 1102-1108.
5. Upadhyaya K, Barwick K, Fishaut M, et al. The importance of nonrenal involvement in hemolytic-uremic syndrome. Pediatrics 1980; 65: 115-120.
6. Bielaszewska M, Karch H. Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endothelium. Thromb Haemost 2005; 94: 312-318.
7. Dehio C. Bartonella interactions with endothelial cells and erythrocytes. Trends Microbiol 2001; 9: 279-285.
8. Sandvig K. Shiga toxins. Toxicon 2001; 39: 1629-1635.
9. Müthing J, Schweppe CH, Karch H, et al. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury. Thromb Haemost 2009; 101: 252-264.
10. Janka A, Bielaszewska M, Dobrindt U, et al.. Cytolethal distending toxin gene cluster in enterohemorrhagic Escherichia coli O157:H- and O157:H7: characterization and evolutionary considerations. Infect Immun 2003; 71: 3634-3638.
11. Friedrich AW, Lu S, Bielaszewska M, et al. Cytolethal distending toxin in Escherichia coli O157:H7: spectrum of conservation, structure, and endothelial toxicity. J Clin Microbiol 2006; 44: 1844-1846.
12. Bielaszewska M, Fell M, Greune L, et al.. Characterization of cytolethal distending toxin genes and expression in Shiga toxin-producing Escherichia coli strains of non-O157 serogroups. Infect Immun 2004; 72: 1812-1816.
13. Schmidt H, Beutin L, Karch H. Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933. Infect Immun 1995; 63: 1055-1061.
14. Bielaszewska M, Sinha B, Kuczius T, et al. Cytolethal distending toxin from Shiga toxin-producing Escherichia coli O157 causes irreversible G2/M arrest, inhibition of proliferation and death of human endothelial cells. Infect Immun 2005; 73: 552-562.
15. Schmidt H, Maier E, Karch H, et al. Pore-forming properties of the plasmid-encoded hemolysin of enterohemorrhagic Escherichia coli O157:H7. Eur J Biochem 1996; 241: 594-601.
16. Aldick T, Bielaszewska M, Zhang W. et al. Hemolysin from Shiga toxin-negative Escherichia coli O26 strains injures microvascular endothelium. Microbes Infect 2007; 9: 282-290.
17. Paton AW, Srimanote P, Talbot UM, et al. A new family of potent AB5 cytotoxins produced by Shiga toxigenic Escherichia coli. J Exp Med 2004; 200: 35-46.
18. Leunk RD, Johnson PT, David BC, et al. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol 1988; 26: 93-99.
19. Zhang W, Bielaszewska M, Friedrich AW, et al. Transcriptional analysis of genes encoding Shiga toxin 2 and its variants in Escherichia coli. Appl Environ Microbiol 2005; 71: 558-561.
20. Brzuszkiewicz E, Bruggemann H, Liesegang H, et al. How to become a uropathogen: Comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc Natl Acad Sci USA 2006; 103: 12879-12884.
21. Welch RA, Burland V, Plunkett G. III, et al. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci USA 2002; 99: 17020-17024.
22. Stins MF, Gilles F, Kim KS. Selective expression of adhesion molecules on human brain microvascular endothelial cells. J Neuroimmunol 1997; 76: 81-90.
23. van Setten PA, van Hinsbergh VWM, van der Velden TJAN, et al. Effects of TNF on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells. Kidney Int 1997; 51: 1245-1256.
24. Cover TL, Reddy LY, Blaser MJ. Effects of ATPase inhibitors on the response of HeLa cells to Helicobacter pylori vacuolating toxin. Infect Immun 1993; 61: 1427-1431.
25. Coelho A, Andrade JR, Vicente AC, et al. Cytotoxic cell vacuolating activity from Vibrio cholerae hemolysin. Infect Immun 2000; 68: 1700-1705.
26. Figueroa-Arredondo P, Heuser JE, Akopyants NS, et al. Cell vacuolation caused by Vibrio cholerae hemolysin. Infect Immun 2001; 69: 1613-1624.
27. Kügler S, Böcker K, Heusipp G, et al. Pertussis toxin transiently affects barrier integrity, organelle organization and transmigration of monocytes in a human brain microvascular endothelial cell barrier model. Cell Microbiol 2007; 9: 619-632.
28. Nicoletti I, Migliorati G, Pagliacci MC, et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide and flow cytometry. J Immunol Methods 1991; 139: 271-279.
29. Kemper B, Carl D, Höink A, et al. Modular digital holographic microscopy system for marker-free quantitative phase contrast imaging of living cells. Proc SPIE 2006; 6191: 61910T.1-61910T.8.
30. Kemper B, Carl D, Schnekenburger J, et al. Investigation of living pancreas tumor cells by digital holographic microscopy. J Biomed Opt 2006; 11: 34005.
31. Tomb JF, White O, Kerlavage AR, et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997; 388: 539-547.
32. Parreira VR, Gyles CL. A novel pathogenicity island integrated adjacent to the thrW tRNA gene of avian pathogenic Escherichia coli encodes a vacuolating autotransporter toxin. Infect Immun 2003; 71: 5087-5096.
33. Guyer DM, Henderson IR, Nataro JP, et al. Identification of Sat, an autotransporter toxin produced by uropathogenic Escherichia coli. Mol Microbiol 2000; 38: 53-66.
34. Ewers C, Janssen T, Kiessling S, et al. Molecular epidemiology of avian pathogenic Escherichia coli (APEC) isolated from colisepticemia in poultry. Vet Microbiol 2004; 104: 91-101.
35. Cover TL, Puryear W, Perez-Perez GI, et al. Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin. Infect Immun 1991; 59: 1264-70.
36. Bowman EJ, Siebers A, Altendorf K. Bafilomycins: a class of inhibitors of membrane ATPases from micro-organisms, animal cells, and plant cells. Proc Natl Acad Sci USA 1988; 85: 7972-7976.
37. Papini E, Bugnoli M, De Bernard M, et al. Bafilomycin A1 inhibits Helicobacter pylori-induced vacuolization of HeLa cells. Mol Microbiol 1993;7: 323-327.
38. Szabò I, Brutsche S, Tombola F, et al. Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. EMBO J 1999;18: 5517-5527.
39. Cover TL, Blanke SR. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat Rev Microbiol 2005; 3: 320-332.
40. Holtzman E. Lysosomes. Springer Verlag, 2007.
41. Salvadori MR, Yano T, Carvalho HE, et al. Vacuolating cytotoxin produced by avian pathogenic Escherichia coli. Avian Dis. 2001; 45: 43-51.
42. Guyer DM, Radulovic S, Jones FE, et al. Sat, the secreted autotransporter toxin of uropathogenic Escherichia coli, is a vacuolating cytotoxin for bladder and kidney epithelial cells. Infect Immun 2002; 70: 4539-4546.
43. Mitra R, Figueroa P, Mukhopadhyay AK, et al. Cell vacuolation a manifestation of the El Tor hemolysin of Vibrio cholerae. Infect. Immun 2000; 68: 1928-1933.
44. Hertle R, Hilger M, Weingardt-Kocher S, et al. Cytotoxic action of Serratia marcescens hemolysin on human epithelial cells. Infect Immun 1999; 67: 817-825.
45. Abrami L, Fivaz M, Glauser PE, et al. A pore-forming toxin interacts with a GPI-anchored protein and causes vacuolation of the endoplasmic reticulum. J Cell Biol 1998; 140: 525-540.
46. Morinaga N, Yahiro K, Matsuura G, et al. Two distinct cytotoxic activities of subtilase cytotoxin produced by shiga-toxigenic Escherichia coli. Infect Immun 2007; 75: 488-496.
47. Papini E, de Bernard M, Milia E, et al. Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartments. Proc Natl Acad Sci USA 1994; 91: 9720-9724.
48. Molinari M, Galli C, Norais N, et al. Vacuoles induced by Helicobacter pylori toxin contain both late endosomal and lysosomal markers. J Biol Chem 1997; 272: 25339-25344.
49. Reading NC, Torres AG, Kendall MM, et al. A novel two-component signaling system that activates transcription of an enterohemorrhagic Escherichia coli effector involved in remodeling of host actin. J Bacteriol 2007; 189: 2468-2476.
50. Guimarães MS, Andrade JR, Freitas-Almeida AC, et al. Aeromonas hydrophila vacuolating activity in the Caco-2 human enterocyte cell line as a putative virulence factor. FEMS Microbiol Lett 2002; 207: 127-131.
51. Kang G, Pulimood AB, Koshi R, et al. A monkey model for enterohemorrhagic Escherichia coli infection. J Infect Dis 2001; 184: 206-210.